Advertisement
Advertisement
HAE
Haemonetics Corporation
55.12
USDSponsored
+0.75
+1.38%
May 08, 16:00 UTC -4
Closed
After-Market
54.77
-0.35
-0.63%
HAE Earnings Reports
Positive Surprise Ratio
HAE beat 35 of 41 last estimates.
85%
Next Report
Date of Next Report
Aug 05, 2026
Estimate for Q1 27 (Revenue/ EPS)
$336.04M
/$1.17
Implied change from Q4 26 (Revenue/ EPS)
-2.98%
/-9.30%
Implied change from Q1 26 (Revenue/ EPS)
+4.56%
/+6.36%
Haemonetics Corporation earnings per share and revenue
On May 07, 2026, HAE reported earnings of 1.29 USD per share (EPS) for Q4 26, beating the estimate of 1.28 USD, resulting in a 0.42% surprise. Revenue reached 346.35 million, compared to an expected 340.23 million, with a 1.80% difference. The market reacted with a +3.23% price change (close before vs. close after earnings).
Looking ahead to Q1 27, 8 analysts forecast an EPS of 1.17 USD, with revenue projected to reach 336.04 million USD, implying an decrease of -9.30% EPS, and decrease of -2.98% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Lantheus Holdings, Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.26
Actual
$1.46
Surprise
+15.85%
ICU Medical Inc
Report Date
May 07, 2026 For Q1 26
Estimate
$1.78
Actual
$1.97
Surprise
+10.26%
BioLife Solutions Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.02
Actual
$0.04
Surprise
+96.08%
Maravai LifeSciences Holdings, Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.04
Actual
$0.01
Surprise
+120.79%
Varex Imaging Corporation Common Stock
Report Date
May 07, 2026 For Q2 26
Estimate
$0.21
Actual
$0.21
Surprise
-1.82%
InfuSystem Holdings, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.03
Actual
$0.05
Surprise
+46.63%
Apyx Medical Corporation Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.10
Actual
-$0.05
Surprise
+53.75%
Rockwell Medical, Inc. (DE) Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
-$0.04
Surprise
-56.86%
Nephros Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.01
Actual
$0.01
Surprise
-1.96%
Myomo Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.11
Actual
-$0.09
Surprise
+21.81%
FAQ
What were Haemonetics Corporation's earnings and revenue for the latest quarter Q4 2026?
For Q4 2026, Haemonetics Corporation reported EPS of $1.29, missing estimates by 0.42%, and revenue of $346.35M, 1.8% above expectations.
How did the market react to Haemonetics Corporation's Q4 2026 earnings?
The stock price moved up 3.23%, changed from $52.67 before the earnings release to $54.37 the day after.
When is Haemonetics Corporation expected to report next?
The next earning report is scheduled for Aug 05, 2026.
What are the forecasts for Haemonetics Corporation's next earnings report?
Based on 8
analysts, Haemonetics Corporation is expected to report EPS of $1.17 and revenue of $336.04M for Q1 2027.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement